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CASE REPORT
Acute hypercalcemia and hypervitaminosis D associated
with pulmonary tuberculosis in an elderly patient : 
A case report and review of the literature.
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Abstract : An 80-year-old man was referred to our hospital for further examination of fever, cough and left pleu-
ral effusion. The laboratory findings showed acute inflammation, and the elevation of albumin-corrected serum 
calcium and 1,25-dihydroxyvitamin D3. A chest CT revealed centrilobular particulate opacity in the bilateral lung 
fields and left pleural effusion, indicating acute hypercalcemia and hypervitaminosis D associated with pulmo-
nary tuberculosis. By the confirmation of Mycobacterium tuberculosis on polymerase chain reaction and cultures 
of the sputum and pleural effusion, a diagnosis of pulmonary tuberculosis was made. The patient successfully 
completed a 9-month course of the anti-tuberculosis treatment, and bilateral infiltrative shadows and left pleural 
effusion in chest X-ray disappeared. Symptoms progressively improved and serum level of albumin-corrected cal-
cium and 1,25-dihydroxyvitamin D3 eventually normalized. While pulmonary tuberculosis is an infrequent cause 
of hypercalcemia, it should be considered in patients with hypercalcemia and elevated serum level of 1,25-dihy-
droxyvitamin D3. J. Med. Invest. 66 : 351-354, August, 2019
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INTRODUCTION
 
The most important causes of hypercalcemia in the elderly are 
hyperparathyroidism, malignant disease and prolonged immo-
bilization. Medications, such as thiazide diuretics and lithium, 
as well as excessive supplementation with calcium/vitamin D, 
may precipitate hypercalcemia (1). Granulomatous disorders, 
such as sarcoidosis and tuberculosis, can also potentially present 
with hypercalcemia. Although hypercalcemia is known to be as-
sociated with pulmonary tuberculosis, it is relatively uncommon 
(2, 3). We herein report an elderly case of pulmonary tuberculosis 
with hypercalcemia and hypervitaminosis D. In the present re-
port, we highlight pulmonary tuberculosis as a potential cause 
of hypercalcemia and hypervitaminosis D, as well as discuss the 
prevalence and the putative mechanisms of tuberculous hyper-
calcemia through the review of the literature. 
CASE REPORT
An 80-year-old man was referred to our hospital for further 
examination of left pleural effusion. On admission, low grade 
fever and productive cough had persisted for approximately nine 
months. His medical history included hypertension, vibration 
disease and fracture of left clavicle. No significant social or family 
history was reported. His body temperature was 36.7 ℃, a blood 
pressure of 110/74 mmHg, a pulse of 60 beats per minute and 
an oxygen saturation of 97% on room air. There were no evident 
cervical, supraclavicular and axillar lymphadenopathies. The 
cardiovascular examination was unremarkable. Respiratory 
sounds were decreased in the left lower lung field. The remain-
der of the physical examination was normal. The laboratory 
findings on admission indicate acute inflammation (white blood 
cell count 6500/μL, C-reactive protein 4.35 mg/dL) and renal 
dysfunction (urea nitrogen 27.8 mg/dL, creatinine 2.94 mg/
dL). The albumin-corrected serum calcium (corrected Ca) and 
1,25-dihydroxyvitamin D3 (1,25-(OH)2D3) were elevated at 12.4 
mg/dL and 151.0 pg/mL, respectively, but intact parathyroid hor-
mone (PTH), PTH-related protein and angiotensin converting 
enzyme were within normal range. The remainder of laboratory 
test results is shown in Table 1. A chest X-ray demonstrated 
bilateral infiltrative shadows and left massive pleural effusion 
(Fig. 1A). A chest CT revealed centrilobular particulate opacities 
and consolidations in the bilateral lung fields and left massive 
pleural effusion (Fig. 1B). Several differential diagnoses were 
considered at this juncture. In our patient, there was neither 
a reported history of excessive calcium/vitamin D intake nor 
consumption of thiazides. Laboratory tests and systemic radio-
logical scans excluded any malignancies and endocrinopathies. 
In view of the radiological findings, a diagnosis of hypercalcemia 
and hypervitaminosis D secondary to pulmonary tuberculosis 
was formulated. By the confirmation of Mycobacterium tubercu-
losis on polymerase chain reaction and cultures of the sputum 
and pleural effusion, a diagnosis of pulmonary tuberculosis 
(bIII2, lPl ; The classification of The Japanese Society for Tu-
berculosis) was made. The isolated strain was susceptible to all 
anti-tuberculosis drugs. Immediately after diagnosis, the patient 
received an anti-tuberculosis treatment comprising daily dosing 
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of isoniazid (INH) 300 mg and rifampicin (RFP) 450 mg, and 
alternate-day administration of ethambutol (EB) 750 mg for 
two months followed by daily dosing of INH and RFP for seven 
months. The dose of EB was adjusted according to the degree 
of renal dysfunction. In terms of treatment for hypercalcemia, 
intravenous saline was also administered. After receiving these 
treatments, the patient’s symptoms progressively improved 
and serum level of corrected Ca and 1,25-(OH)2D3 eventually 
normalized at 9.0 mg/dL and 29.6 pg/mL, respectively. Finally, 
the patient successfully completed a 9-month course of the 
anti-tuberculosis treatment, and bilateral infiltrative shadows 
and pleural effusion in chest X-ray and chest CT disappeared 
(Fig. 2A, B).
 
Table 1.　Laboratory data on admission
Hematology Na 136 mEq/L PR3-ANCA < 1.0 U/mL
WBC 6,500 /μL K 4.4 mEq/L MPO-ANCA < 1.0 U/mL
Neu   80.9 % Cl 410 mEq/L
Lymph 9.8 % Ca 11.6 mg/dL Urinalysis
Mono 7.6 % P 4.1 mg/dL pH 6.5
Eos 1.1 % CRP 4.35 mg/dL specific gravity 1.009
Baso 0.6 % HbA1c (NGSP) 5.9 % Sugar －
RBC 368×104 /μL BS 129 mg/dL Occult blood ±
Hb 10.3 g/dL 1,25(OH)2D3 151 pg/mL Protein －
Ht  30.8 % intact PTH 7 pg/mL Sediment W.N.L.
Plt 43.2×104 /μL PTHrP < 1.0 pmol/L
Biochemistry ACE 3.1 IU/L Analysis for acid-fast bacilli
AST 48 IU/L KL-6 404 U/mL Sputum
ALT 44 IU/L β-D-glucan < 5.0 pg/mL Smear －
ALP 214 IU/L Culture ＋
LDH 299 IU/L Immunology TB-PCR ＋
γ-GTP 24 IU/L IgG 1,177 mg/dL MAC-PCR －
T-bil 0.59 mg/dL IgA 334 mg/dL Pleural effusion
CK 261 U/L IgM 79 mg/dL Smear －
TP 6.5 g/dL C3 113 mg/dL Culture ＋
Alb 3.2 g/dL C4 38 mg/dL TB-PCR ＋
BUN 27.8 mg/dL CH50 45.8 U/mL MAC-PCR －
Cre 2.94 mg/dL anti-nuclear antibody < 40
ACE, angiotensin-converting enzyme ; KL-6, krebs von den lungen-6 ; ANCA, antineutrophil cytoplasmic antibody ; TB, tuberculosis ; 
MAC, Mycobacterium-avium complex
Figure 1.　Chest X-ray and Chest CT on admission. Bilateral infiltrative shadows and left massive pleural effusion were evident in chest 
X-ray (Figure 1A). A chest CT revealed centrilobular particulate opacities and consolidations in the bilateral lung fields and left massive pleural 
effusion (Figure 1B).
Figure 1A
Figure 1B
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DISCUSSION
The present case reminds us of the importance of pulmonary 
tuberculosis as a cause of hypercalcemia especially in elderly 
patients. While pulmonary tuberculosis is an infrequent cause 
of hypercalcemia (4), it should be considered in patients with 
hypercalcemia and elevated serum level of 1.25-(OH)2D3. When-
ever pulmonary tuberculosis is suspected, timely diagnosis and 
treatment are mandatory.
Main causes of hypercalcemia include primary hyperpara-
thyroidism, malignancies, drugs and granulomatous diseases, 
although relative frequency is different between various regions 
(5). Primary hyperparathyroidism is the most frequent cause, 
but cancer and drugs have been recently identified as the causes 
with increased frequency, especially in elderly patients because 
of the greater risk for malignancy and increased use of vitamin 
D supplements. However, following these three major causes 
of hypercalcemia, granulomatous diseases remain important 
causes for hypercalcemia and these include sarcoidosis, histo-
plasmosis, coccidioidomycosis and candidiasis in addition to 
tuberculosis. Finally, other rare causes include hyperthyroidism. 
Investigations for causes of hypercalcemia include detailed his-
tory-taking, physical examination and logical use of laboratory 
tests. The use of vitamin D or calcium should be sought and 
physical examination should be performed for looking for a clue 
suggestive of possible malignancy or granulomatous diseases.
The prevalence of hypercalcemia in patients with tuberculosis 
is quite variable between countries, varying from approximately 
2.3% in some studies (3) to 14.7-50.6% in other studies (6-14) 
(Table 2). This variation has been largely attributed to disparity 
in vitamin D and calcium intake, the degree of sunlight exposure 
as well as the criteria for the diagnosis for hypercalcemia (4). 
Generally, studies using the albumin-adjusted serum calcium 
concentration have reported higher prevalence rates compared 
with patients who did not use correction (7, 9). In the elderly pa-
tient with tuberculosis, the frequency of hypercalcemia has not 
been well documented. Although clinically significant hypercal-
cemia from tuberculosis is relatively uncommon, the elderly pa-
tient seems to be particularly susceptible, given their advanced 
age, comorbidities, polypharmacy as well as the frequent use of 
calcium/vitamin D supplements. In the present case, serum level 
of corrected Ca and 1,25-(OH)2D3 eventually normalized with a 
continued treatment of tuberculosis, as reported previously (1). 
Although hypercalcemia associated with pulmonary tuberculo-
sis is relatively uncommon and is rarely symptomatic, prompt 
diagnosis and appropriate treatment is very important.
The mechanism of tuberculous hypercalcemia remains un-
clear, but has been largely attributed to vitamin D dysregula-
tion. Patients presenting with tuberculosis tend to have lower 
levels of vitamin D than healthy individuals (15). In patients 
with tuberculosis, extrarenal synthesis of active vitamin D, 
1,25(OH)2D3, occurs via 1-α-hydroxylase produced by interferon 
Figure 2.　Chest X-ray and Chest CT after a 9-month course of the anti-tuberculosis treatment. Bilateral infiltrative shadows and left pleural 
effusion disappeared in both chest X-ray (Figure 2A) and chest CT (Figure 2B).
Figure 2A
Figure 2B
Table 2.　Summary of the prevalence of hypercalcemia in pulmonary tuberculosis
Author Year Country N Prevalence Methodology* Reference No.
Abbasi AA 1979 U.S.A. 79 27.8% Ionized calcium 6
Need AG 1980 Australia 89 50.6% Albumin-adjusted calcium 7
Sharma SC 1981 India 94 15.5% Ionized calcium 8
Kitrou MP 1983 Greece 50 48.0% Albumin-adjusted calcium 9
Lind L 1990 Sweden 67 25.4% Ionized calcium 10
Tan TT 1993 Malaysia 43 2.3% Ionized calcium 3
Chan TY 1994 China 34 5.9% Ionized calcium 11
Chan TY 1994 China 34 14.7% Albumin-adjusted calcium 11
Liam CK 1998 Malaysia 120 27.5% Albumin-adjusted calcium 12
Roussos A 2001 Greece 88 25.0% Albumin-adjusted calcium 13
Dosumu EA 2006 Nigeria 120 27.5% Albumin-adjusted calcium 14
*Methodology for the diagnosis of hypercalcemia
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gamma (IFN-γ)-activated T lymphocytes and alveolar macro-
phages (16, 17), which results in increased enteric absorption 
of calcium. In vitro, vitamin D promotes mycobacterial killing in 
macrophages through production of nitric oxide (18), as well as 
the antimicrobial peptide cathelicidin LL-37, after activation of 
macrophages via either Toll-like receptor or IFN-γ release (19, 
20), and by inducing phagolysosyme fusion and autophagy (20, 
21). These effects have been shown to be local (22) and does not 
normally affect overall calcium homeostasis. In addition, 1,25-
(OH)2D3 induces 24-(OH) hydroxylase expression, which deacti-
vates 1,25-(OH)2D3 to calcitroic acid. However, it is believed that 
if large quantities of 1,25-(OH)2D3 are produced, a ‘spillover’ 
effect may occur in the circulation and potentially result in 
hypercalcemia (23). It should be also kept in mind that RFP 
and INH may alter concentrations of serum 25-hydroxyvitamin 
D3 and 1,25-(OH)2D3 and thereby reduce the degree of hyper-
calcemia. RFP induces several enzymes (CYP3A4, CYP24A1, 
and uridine 5’-diphospho-glucuronyltransferases) that degrade 
25-hydroxyvitamin D3 and, by reducing substrate, reduce 1,25-
(OH)2D3 concentrations (24). In contrast, INH inhibits 1,25-
(OH)2D3 synthesis (13). Further study is warranted to elucidate 
the appropriate mechanism of tuberculous hypercalcemia.
In conclusion, we herein report a case of pulmonary tuberculo-
sis with hypercalcemia and hypervitaminosis D and discuss the 
prevalence and the putative mechanisms of tuberculous hyper-
calcemia through the review of the literature. While pulmonary 
tuberculosis is an infrequent cause of hypercalcemia, it should be 
considered in patients with hypercalcemia and elevated serum 
level of 1.25-(OH)2D3 especially in the elderly.
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